Browse the full insider trade history of MBX Biosciences, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.4bn. The latest transaction was reported on 10 April 2025 (Acquisition). Among the most active insiders: GORDON CARL L. Every trade is openly available.
22
Insider Decl.
0
Thresholds
€898,775
4 ops.
Buy Volume
·
0 ops.
Sell Volume
49Σ signal
Buys €898,775· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.